尽管净收入下降,但Elevance Health报告了强的2025年第一季度收益,超过预期. Elevance Health reports strong Q1 2025 earnings, exceeding expectations despite a drop in net income.

埃莱万斯健康报告了强的2025年第一季度收入,收入为487亿美元,每股收益为11.97美元,两者都超过预期. Elevance Health reported strong Q1 2025 earnings, with revenue of $48.77 billion and EPS of $11.97, both surpassing expectations. 尽管净收入略有下降,降至21.8亿美元,但该公司的会员数目和业务收入有所增加。 Despite a slight decrease in net income to $2.18 billion, the company saw growth in memberships and operating revenue. 机构投资者J. Safra Sarasin Holding AG降低了其在 " 高健康 " 中的份额,但该公司保持了 " 中购 " 评级,平均价格目标为508.81美元。 Institutional investor J. Safra Sarasin Holding AG reduced its shares in Elevance Health, but the company maintains a "Moderate Buy" rating with an average price target of $508.81.